Appendix for patients on weight loss therapy GLP-1 launched in Russia

In Russia, for the first time, an application has been launched that combines data on GLP-1-based weight loss drugs with tools to help patients sustainably control body weight.

The company GEROPHARM reported that in the application Stroynee for users of therapy Sejaro, Semavik and Semavik Next created separate educational programs. This is reported by newstula.ru. With their help, you can track the dosage and schedule of injections, as well as nutrition, physical activity and emotional state. The service provides materials from doctors and experts, video training with the participation of Olympic champion Irina Slutskaya, as well as a game “hero card” with daily tasks and incentives. The developers hope that this format will help patients stay motivated, lose weight and consolidate new habits with less psychological stress.

The effectiveness of mobile services in weight control is confirmed by a study of an international team of scientists. According to their findings, the use of mobile applications provides a statistically significant and sustained reduction in body weight and waist circumference. Conventional web resources did not show a comparable effect: the mobile format plays an important role, which provides constant access to monitoring and support tools.

GEROPHARM CEO Peter Rodionov stressed that digital tools are designed to reduce psychological barriers in therapy, including fear of injections and a lack of structured information, as well as provide patients with a measurable outcome.